BioGaia revises dividend policy

According to BioGaia's previous dividend policy, 40 per cent of the profit after tax in the Parent Company will be distributed to the shareholders. The Board of Directors of BioGaia has chosen to revise the dividend policy so that 50 per cent of the profit after tax in the Parent Company will be distributed to the shareholders.

Latest press releases from BioGaia
27.01.2021    BioGaia invests in Sweden – launches its entire adult health portfolio
30.11.2020    New number of shares and votes in BioGaia
25.11.2020    Extraordinary General Meeting of BioGaia

This is information that BioGaia AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, on 3 February 2021 at 07:00 pm CET.
 

For additional information please contact
Isabelle Ducellier, CEO: +46 8 555 293 00

BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in more than 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com